Study of the neutrophil myelo- peroxidase index (MPXI) with blood disorders, immune disorders or circulatory diseases

Study of the neutrophil myelo- peroxidase index (MPXI) with blood disorders, immune disorders or circulatory diseases - Study of the neutrophil myelo- peroxidase index (MPXI) with blood disorders, immune disorders or circulatory diseases

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004038

Enrollment

300

Registered

2010-08-12

Start date

2010-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blood, immune disorders and circulatory diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who had a diagnosis of blood disorder, immune disorder or circulatory disease by a biochemical test, an immunologic test and a hematologic test including a smear examination

Exclusion criteria

Exclusion criteria: 1)Inappropriate patients for this study judged by the diagnosticians 2)Patients cannot agree to participate in this trial.

Design outcomes

Primary

Measure	Time frame
1)Correlation between inflammatory marker and MPXI in inflammatory disorder or immune disorder 2)Correlation between morphologic diagnosis using a smear observation and MPXI in leukemia, MDS, or MPO deficiency 3) Correlation between Troponin one or CK-MB and MPXI in ischemic heart disease	—

Countries

Japan

Contacts

Public ContactKenji Yonezawa

Kobe University Graduate School of Health Sciences Division of Medical Biophysics

k.yonezawa717@gmail.com078-929-1151

Outcome results